Quick byte: Curing diabetes


Harvard biologist Doug Melton, PhD, is exploring the use of stem cells to create replacement beta cells that produce insulin, according to Time magazine.

Dr. Doug Melton

In 2014, he co-founded Semma Therapeutics to develop the technology, which was acquired by Vertex Pharmaceuticals.

“The company has created a small, implantable device that holds millions of replacement beta cells, letting glucose and insulin through but keeping immune cells out. ‘If it works in people as well as it does in animals, it’s possible that people will not be diabetic,’ said Dr. Melton, co-director of the Harvard Stem Cell Institute and an investigator of the Howard Hughes Medical Institute. ‘They will eat and drink and play like those of us who are not.’”


Steinberg D. 12 innovations that will change health care and medicine in the 2020s. Time. 2019 Oct 25. Accessed Dec 5, 2019.

Recommended Reading

Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess
The Hospitalist
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
The Hospitalist
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
The Hospitalist
Protecting patients with diabetes from impact of COVID-19
The Hospitalist
DAPT increases bleeding without decreasing mortality in patients with coronary disease and diabetes
The Hospitalist
   Comments ()